Markets › United States › NYSE › NVO

Novo Nordisk AS

NYSE:NVOHealthcare

$39.21+2.06%LiveIn session · ≈ AED 144.00 · Market cap $176.16B · Next earnings Wed 4 Nov

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-08-05	0.82	0.96	+17.1%	10,894.8	12,130.3	+11.3%
2026-08-04	—	0.74	—	—	—	—
2026-05-06	0.87	1.04	+19.5%	10,859.7	11,022.7	+1.5%
2026-02-03	0.90	1.00	+11.1%	12,127.8	12,503.3	+3.1%
2025-11-05	0.77	1.02	+32.5%	11,944.0	11,529.5	−3.5%
2025-08-06	0.93	0.97	+4.3%	11,923.3	11,974.2	+0.4%
2025-05-07	0.92	0.92	+0.0%	11,695.2	11,897.0	+1.7%
2025-02-05	0.88	0.91	+3.4%	11,549.7	11,858.5	+2.7%
2024-11-06	0.87	0.88	+1.4%	10,484.7	10,682.4	+1.9%
2024-08-07	0.70	0.66	−5.9%	10,043.7	9,800.0	−2.4%
2024-05-02	0.74	0.82	+10.5%	9,071.3	9,384.1	+3.4%
2024-01-31	0.66	0.71	+7.6%	9,153.2	9,598.5	+4.9%